Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.
MedPage Today on MSN
Drug Holidays for Advanced Kidney Cancer a Consideration for Selected Patients
DENVER -- Planned treatment "holidays" can help lessen the toxicity burden of tyrosine kinase inhibitors (TKIs) for selected ...
The early stages of chronic kidney disease (CKD) are usually asymptomatic, with kidney function progressively and ...
News-Medical.Net on MSN
Study compares the kidney, cardiovascular and mortality risks of three different GLP-1 RAs
Public interest in drugs known as glucagon-like peptide-1 receptor agonists, also called GLP-1 RAs, has surged in recent ...
"Our findings demonstrate that GLP1-RAs can lead to fewer cardiovascular events, less progression of kidney disease, and lower health care costs," study co-senior author Dr. Ildiko Lingvay said. Adobe ...
These drugs promise faster results with fewer side effects, and in some cases, reversal or slows the disease progression.
Scientists have reversed acute kidney injury in mice by genetically altering ceramide processing, preventing damage to ...
Obesity is one of the biggest barriers preventing patients with end-stage kidney disease from receiving a life-saving kidney ...
Chronic kidney disease (CKD) is a progressive condition in which the kidneys are damaged and can’t filter blood effectively. This can eventually lead to a buildup of waste and fluid in the body. In ...
Researchers uncovered how fatty molecules called ceramides trigger acute kidney injury by damaging the mitochondria that ...
Polycystic kidney disease (PKD) is a debilitating hereditary condition in which fluid-filled sacs form and proliferate in the ...
At the 2025 International Kidney Cancer Symposium, Dr. Michael Staehler, of the University of Munich, highlighted the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results